1.
Luo J, Yuan M, Li S, Chen L, Zhou M, Li H, et al. Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment. Rev. Inst. Med. Trop. São Paulo [Internet]. 2024 May 13 [cited 2024 Jun. 26];66:e27. Available from: https://revistas.usp.br/rimtsp/article/view/225152